US Patent Issued to SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION on May 26 for "Vaccine composition for preventing tuberculosis comprising chorismate mutase" (South Korean Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,636,357, issued on May 26, was assigned to SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (Seoul, South Korea).

"Vaccine composition for preventing tuberculosis comprising chorismate mutase" was invented by Bum Joon Kim (Seoul, South Korea), Byoung Jun Kim (Gyeonggi-do, South Korea), Jaehun Oh (Seoul, South Korea) and Hyejun Seo (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "An aspect provides a vaccine composition for preventing tuberculosis comprising chorismate mutase. The vaccine composition alone may induce immunity specific to Mycobacterium tuberculosis, and when provided together with an immune adjuvant, the vaccine composition may ...